| Plasma malondialdehyde (MDA) levels in breast and lung cancer patients A Gönenç, Y Özkan, M Torun, B Şimşek Journal of clinical pharmacy and therapeutics 26 (2), 141-144, 2001 | 282 | 2001 |
| Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease A Gönenç, D Erten, S Aslan, M Akıncı, B Şimşek, M Torun Cell biology international 30 (4), 376-380, 2006 | 209 | 2006 |
| Lipid peroxidation and total antioxidant status in patients with breast cancer D Erten Şener, A Gönenç, M Akıncı, M Torun Cell Biochemistry and Function: Cellular biochemistry and its modulation by …, 2007 | 161 | 2007 |
| Serum cardiac markers in patients with acute myocardial infarction: oxidative stress, C-reactive protein and N-terminal probrain natriuretic peptide S Kasap, A Gönenç, DE Şener, İ Hisar Journal of clinical biochemistry and nutrition 41 (1), 50-57, 2007 | 122 | 2007 |
| Serum β–carotene, vitamin E, vitamin C and malondialdehyde levels in several types of cancer M Torun, S Yardim, A Gönenç, H Sargin, A Menevse, B Simsek Journal of clinical pharmacy and therapeutics 20 (5), 259-263, 1995 | 84 | 1995 |
| Oxidative stress in patients with essential hypertension: a comparison of dippers and non-dippers A Gönenç, A Hacışevki, Y Tavil, A Çengel, M Torun European journal of internal medicine 24 (2), 139-144, 2013 | 58 | 2013 |
| Changes of sFas and sFasL, oxidative stress markers in serum and follicular fluid of patients undergoing IVF A Pekel, A Gönenç, NÖ Turhan, H Kafalı Journal of assisted reproduction and genetics 32, 233-241, 2015 | 34 | 2015 |
| Oxidative stress in relation to lipid profiles in different stages of breast cancer A Gönenç, D Tokgöz, S Aslan, M Torun CSIR, 2005 | 34 | 2005 |
| Increased oxidative DNA damage and impaired antioxidant defense system in patients with gastrointestinal cancer A Gönenç, A Hacışevki, S Aslan, M Torun, B Şimşek European Journal of Internal Medicine 23 (4), 350-354, 2012 | 25 | 2012 |
| Çeşitli kanser vakalarında serum MDA düzeyleri M Torun, S Yardım, A Gönenç, H Sargın Biyokimya dergisi 20 (1), 1-7, 1995 | 14 | 1995 |
| Accumulation of an endogenous inhibitor of nitric oxide synthesis and oxidative DNA damage in end-stage renal disease. A Hacişevki, A Gönenç, S Sezer, S Karakan, B Simşek, M Torun Clinical Laboratory 59 (11-12), 1353-1361, 2013 | 8 | 2013 |
| Oxidized low-density protein, interleukin-6 and tumor necrosis factor alpha levels and paraoxonase activities in hypertensive patients A Gönenç Turk J. Pharm. Sci 9 (1), 41-50, 2012 | 7 | 2012 |
| Iron metabolism in patients with impaired thyroid function A Onat, A Gönenç, S Gürcan, M Torun Journal of Faculty of Pharmacy of Ankara University 32 (4), 2003 | 6 | 2003 |
| Assessment of vitronectin, soluble epithelial-cadherin and TGF-β1 as a serum biomarker with predictive value for endometrial and ovarian cancers T Turan, M Torun, F Atalay, A Gönenç Turkish Journal of Pharmaceutical Sciences 14 (2), 141, 2017 | 5 | 2017 |
| The effects of thyme tea supplement on free radicals formation and antioxidant system of elite wrestlers CB Alpay, S Hazar, K Gökdemir, NA Güzel, A Gönenç, B Simsek Pakistan Journal of Nutrition 12 (5), 433, 2013 | 4 | 2013 |
| Serum Malondialdehyde, Vitamin E and β‐Carotene Levels in Breast Cancer M Torun, A Gönenç, S YARDIM, H SARGIN, A MENEVSE, B Şimşek Pharmacy and Pharmacology Communications 1 (2), 63-65, 1995 | 3 | 1995 |
| Protein carbonyl content as the most general and well used biomarker of severe oxidative stres. A Hacışevki, B Baba, A Gönenç, S Aslan Oxidation Communications 35 (2), 2012 | 2 | 2012 |
| Serum INHB levels and ACE gene I/D polymorphism with increased risk for unexplained infertility T Turan, A Pekel, ZCİ Duvan, A Gönenç The journal of biochemistry 170 (2), 245-253, 2021 | 1 | 2021 |
| Endometrial ve Ovaryum Kanserinde Tanısal Değer Yönünden Serum Biyobelirteci Olarak Vitronektin, Solubl Epitel-Kaderin ve TGF-β1’in Değerlendirilmesi T TURAN, FM TORUN, F ATALAy, A GÖNENÇ Turkish Journal of Pharmaceutical Sciences 14 (2), 141-147, 2017 | 1 | 2017 |
| Angiotensin II Type I Receptor—168A/G Polymorphism Is Associated with Increased the Risk of Glioma in Turkish Population T Turan, B Özaydın, ÖH Emmez, AM Kaymaz, İI Gönül, M Bozkurt, ... Molecular Biology, 1-17, 2024 | | 2024 |
